Internal Medicine · Acibadem Altunizade Hospital, İstanbul Assoc. Prof. Müjdat Kara, MD
✓ Medically verified profileAssoc. Prof. Müjdat Kara, MD
Assoc. Prof. Müjdat Kara, MD is an Internal Medicine specialist at Acibadem Altunizade Hospital in İstanbul. He evaluates and manages thyroid disorders including thyroid nodules, thyroid cancer, hyperthyroidism, Graves' disease, goiter and Hashimoto's disease, as well as diabetes, prediabetes, gestational diabetes, obesity and morbid obesity. He speaks Turkish and English and offers video consultation.
Accepting international patientsAbout Assoc. Prof. Müjdat Kara, MD
Assoc. Prof. Müjdat Kara, MD is an Internal Medicine specialist practicing at Acibadem Altunizade Hospital in İstanbul, where he works within the Internal Medicine unit. His clinical interests lie in endocrinology and metabolic medicine, including diabetes, thyroid disorders, obesity, menopause, and growth and puberty. He has more than 31 years of experience in medicine and sees adult patients with a range of hormonal and metabolic concerns.
Dr. Kara graduated from Trakya University Faculty of Medicine in 1995. He completed his Internal Medicine training at Trakya University Faculty of Medicine in 2002 and his training in Endocrinology and Metabolic Diseases at the same faculty in 2005. From 2005 to 2009 he worked at Kayseri Training and Research Hospital, followed by Bursa Devlet Hospital in 2009 and Özel Gaziosmanpaşa Hospital from 2009 to 2012. He joined Acıbadem Healthcare Services in 2013. Dr. Kara is a co-author of peer-reviewed publications on topics including silent myocardial ischemia in patients with type 2 diabetes, the effects of rosiglitazone treatment on the fibrinolytic system in type 2 diabetes, global fibrinolytic capacity in subclinical hypothyroidism, exacerbations of Graves’ disease after unilateral adrenalectomy for Cushing’s syndrome, acute painful diabetic neuropathy, and autoimmune polyglandular syndrome type III in monozygotic twins.
Clinical focus
A substantial part of Dr. Kara’s practice concerns thyroid disease. He evaluates and manages thyroid nodules, thyroid cancer, goiter, Hashimoto’s disease, hyperthyroidism and Graves’ disease, as well as other thyroid disorders. In the field of metabolic medicine, he provides diabetes management for patients with type 2 diabetes, prediabetes and gestational diabetes, and he assesses patients with insulin resistance.
Dr. Kara also sees patients with obesity and morbid obesity, offering medical evaluation and follow-up of weight-related metabolic conditions. His further areas of interest include menopause, growth and puberty, pituitary and adrenal conditions, autoimmune endocrine disorders and endocrine pancreatic tumors. Care is planned with attention to each patient’s individual symptoms, test results and treatment needs, and the appropriate approach is decided after clinical assessment.
How Dr. Kara works with international patients
Dr. Kara speaks Turkish and English, and interpreters can be arranged for patients who prefer another language. Before a visit, the Acibadem international patient team coordinates the collection of prior medical reports, laboratory results and imaging, arranges appointments and organises the hospital visit. A first consultation typically covers the patient’s history and current symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the possible options. Video consultation is available for international patients who wish to discuss their situation with Dr. Kara before or after traveling; whether this is suitable depends on the individual case and the information available.
What Dr. Kara treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Areas of practiceInternal medicineThyroid diseases and treatmentMenopozGrowth and puberty
Conditions treated
Education, career and memberships
Education & training
Education
- 2005Trakya University Faculty of Medicine Endocrinology and Metabolic Diseases
- 2002Trakya University Faculty of Medicine Internal Medicine
- 1995Trakya University Faculty of Medicine
Career
Professional Experience
- 2013Acıbadem Healthcare Services
- 2009–2012Özel Gaziosmanpaşa Hospital
- 2009Bursa Devlet Hospital
- 2005–2009Kayseri Training and Research Hospital
Selected publications
Selected Publications
- Autoimmune polyglandular syndrome type III in monozygotic twins: a case report. Ugur-Altun B, Arikan E. Guldiken S, Kara M, Tugrulul
- Silent myocardial ischemia in middle-aged asymptomatic patients with type 2 diabetes in Turkish population Angiology. 2007 Oct-Nov;58(5):535-42. Ugur-Altun B. Altun A, Guldiken S, Tatli E, Kara M, Tugrul A.
- The effects of rosiglitazonc treatment on the fibrinolytic system in patients with type 2 diabetes mcllitus. Clin Appl Thromb I lemost. 2006 Jan; 12( 1 ):55-60. Guldiken S, Turgut B. Demir M, Arikan E, Kara M, Vural O, Tugrul A. Farced J.
- Global fibrinolytic capacity in patients with subclinical hypothyroidism. fibrinolytic capacity in patients with subclinical hypothyroidism. 2005 Jun;52(3):363-7. Guldiken S. Demir M, Turgut B, Altun BU, Arikan E, Kara M. Endow J.
- CompIete relief of pain in acute painful diabetic neuropathy of rapid glycaetnic control (insulin neuritis) with venlafaxine HCL. Diabetes Nufr Metab. 2004 Aug; 17(4):247-9. Guldiken S, Guldiken B, Arikan E, Altun Ugur B, Kara M, Tugrul A.
- Exacerbations of Graves” disease after unilateral adrenaleetomy for Gushing “s syndrome. J Endocrinol Invest. 2004 Jun;27(6):574-6. Arikan E, Guldiken S, AItu n BU. Kara M, Tugrul A.

